1. Home
  2. RMBI vs NKTX Comparison

RMBI vs NKTX Comparison

Compare RMBI & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richmond Mutual Bancorporation Inc.

RMBI

Richmond Mutual Bancorporation Inc.

HOLD

Current Price

$13.94

Market Cap

132.9M

Sector

Finance

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.07

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBI
NKTX
Founded
1887
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.9M
132.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
RMBI
NKTX
Price
$13.94
$2.07
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$13.25
AVG Volume (30 Days)
16.4K
728.8K
Earning Date
01-23-2026
11-10-2025
Dividend Yield
4.33%
N/A
EPS Growth
21.88
N/A
EPS
1.06
N/A
Revenue
$44,970,551.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.09
N/A
Revenue Growth
6.42
N/A
52 Week Low
$11.37
$1.31
52 Week High
$15.24
$2.74

Technical Indicators

Market Signals
Indicator
RMBI
NKTX
Relative Strength Index (RSI) 52.14 61.29
Support Level $13.86 $1.79
Resistance Level $14.19 $2.19
Average True Range (ATR) 0.20 0.09
MACD -0.03 0.03
Stochastic Oscillator 56.66 67.06

Price Performance

Historical Comparison
RMBI
NKTX

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: